在临床前模型中，ALK抑制剂可抑制HCC并与抗PD-1疗法和ABT-263协同作用

{"title":"在临床前模型中，ALK抑制剂可抑制HCC并与抗PD-1疗法和ABT-263协同作用","authors":"S. Bugide, Dhana Sekhar Reddy, P. Malvi, Romi Gupta, N. Wajapeyee","doi":"10.1016/j.isci.2024.109800","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508122,"journal":{"name":"iScience","volume":"669 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models\",\"authors\":\"S. Bugide, Dhana Sekhar Reddy, P. Malvi, Romi Gupta, N. Wajapeyee\",\"doi\":\"10.1016/j.isci.2024.109800\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508122,\"journal\":{\"name\":\"iScience\",\"volume\":\"669 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"iScience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.isci.2024.109800\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"iScience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.isci.2024.109800","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}